SCHEMBL5824599

SCHEMBL5824599

CCCc1ccc(C(=O)N=C=S)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 2/20 0.50
THRB P10828 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.47
POLB P06746 3/20 0.45
CTDSP1 Q9GZU7 3/20 0.45
ALDH1A1 P00352 3/20 0.45
GAA P10253 2/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPT P10636 1/20 0.44
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
RARB P10826 2/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
THRA P10827 1/20 0.39
LPL P06858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5825039 0.90 RARB (0.53) PLK1THRBALDH1A1KMT2AMAPT
SCHEMBL5824641 0.87 THRA (0.55) THRBALDH1A1KMT2AMAPTRARB
SCHEMBL5825026 0.86 ALDH1A1 (0.52) PLK1POLBALDH1A1GAANPC1
SCHEMBL484049 0.81 TP53 (0.35) MAPTESR1ESR2LMNA
SCHEMBL6280445 0.80 THRB (0.50) PLK1THRBL3MBTL1POLBCTDSP1
SCHEMBL5824368 0.79 CA1 (0.50) THRBPOLBALDH1A1RAB9AKMT2A
SCHEMBL12086481 0.78 PLK1 (0.56) PLK1THRBL3MBTL1POLBCTDSP1
SCHEMBL2892447 0.76 ALDH1A1 (0.48) THRBALDH1A1GAANPC1RAB9A
SCHEMBL20258185 0.76 NOS3 (0.44) L3MBTL1ALDH1A1GAAKDM4ENPC1
SCHEMBL5824697 0.76 TP53 (0.54) L3MBTL1ALDH1A1GAARAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA PLK1 1738/4885THRB 298/4885L3MBTL1 1545/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA PLK1 1286/4885THRB 362/4885L3MBTL1 1895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.